Biotechnology has not stood still since 1991 when the first edition of Biotechnology - The Science and the Business was published. It was the first book to treat the science and business of technology as an integrated subject and was well received by both students and business professionals. All chapters in this second edition have been updated and revised and some new chapters have been introduced, including one on the use of molecular genetic techniques in forensic science. Experts in the field discuss a range of biotechnologies, including pesticides, the flavor and fragrance industry, oil production, fermentation and protein engineering. On the business side, subjects include managing, financing, and regulation of biotechnology. Some knowledge of the science behind the technologies is assumed, as well as a layperson's view of buying and selling. As with the first edition, it is expected that this book will be of interest to biotechnology undergraduates, postgraduates and those working in the industry, along with students of business, economics, intellectual property law and communications.
Table of Contents
Section I: Matters of Business: Managing a Biotechnology Business. Financing Biotechnology Companies. Biotechnology Startups. Patents: Paradigms in Collision. Intellectual Property and Technical Know-How Public Perceptions of Biotechnology. The Regulation of Biotechnology in the United States. The Regulation of Biotechnology in Europe. Communication. Section II: Underlying Technologies and Economics: Polymerase Chain Reaction Development of a Novel Technology in a Corporate Environment. Protein Engineering. Fermentation Technology, Bioprocessing, Scale-up and Manufacture. Feedstocks. Process Economics. Section III: Biotechnology and Industry: The Established Industries. Industrial Chemicals: Fermentation and Immobilized Cells. Industrial Enzymes. New Materials. Biosensors.
Derek G. Springham (Queen Mary and Westfield College, University of London, UK) (Edited by) , Vivian Moses (King's College, University of London, London, UK) (Edited by) , Ronald E. Cape (Ronald Cape Biotechnology Investments, San Francisco, CA, US) (Edited by)